Wuxi Taxus Pharmaceutical Co., Ltd is a High-Tech pharmaceutical enterprise with GMP and DMF. We are specially engaged in anticancer APIs, such as Paclitaxel(DMF:25759), Docetaxel, Cabazitaxel, Oxaliplatin, Irinotecan, Decitabine, Allopurinol, Ramosetron, Granisetron, Praziquantel,10-DAB，side chains and other anticancer Intermediates, APIs and Injections. Also we doing Custom-Synthesis and Toll manufacturing. Paclitaxel and Oxaliplatin registered in India, Korea etc.
Year Established: 2004
Total Assets(USD): choose not to disclose
Total Number of Staff: 150 to 199
Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff
Business Type: Manufacturer
Annual Turnover(USD) : choose not to disclose
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Subscribe to the latest newsletter of Virtual Expo Connect
Oxaliplatin